Cost-effectiveness analysis of extended adjuvant endocrine therapy in the treatment of post-menopausal women with hormone receptor positive breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-014-2950-6
Published Online: 2014-04-26
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Erman, Aysegul
Nugent, Arlene
Amir, Eitan
Coyte, Peter C.
Text and Data Mining valid from 2014-04-26